F Gambi

Summary

Affiliation: University of Chieti
Country: Italy

Publications

  1. ncbi request reprint Effect of mirtazapine on thyroid hormones in adult patients with major depression
    F Gambi
    Department of Oncology and Neurosciences, Institute of Psychiatry, University G D Annunzio, Chieti, Italy
    Int J Immunopathol Pharmacol 18:737-44. 2005
  2. ncbi request reprint Mirtazapine treatment of generalized anxiety disorder: a fixed dose, open label study
    Francesco Gambi
    Department of Oncology and Neurosciences, Institute of Psychiatry, University G d Annunzio of Chieti, Chieti, Italy
    J Psychopharmacol 19:483-7. 2005
  3. ncbi request reprint Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder
    D De Berardis
    Department of Oncology and Neurosciences, Institute of Psychiatry, G D Annunzio University, Chieti, Italy
    J Biol Regul Homeost Agents 22:195-200. 2008
  4. ncbi request reprint Evaluation of C-reactive protein and total serum cholesterol in adult patients with bipolar disorder
    D De Berardis
    Department of Oncology and Neurosciences, Institute of Psychiatry, G D Annunzio University of Chieti, Palazzina SE BI, Scuole di Specializzazione, Via dei Vestini 29, Chieti, Italy
    Int J Immunopathol Pharmacol 21:319-24. 2008
  5. ncbi request reprint The role of C-reactive protein in mood disorders
    D De Berardis
    Institute of Psychiatry, Department of Oncology and Neurosciences, University of Chieti, Chieti, Italy
    Int J Immunopathol Pharmacol 19:721-5. 2006
  6. ncbi request reprint An Italian study on health-related quality of life and fatigue in patients with chronic fatigue syndrome and patients with chronic HCV virus infection: similarities and differences
    Delia Racciatti
    Clinic of Infectious Diseases, Department of Medicine and Aging, G D Annunzio University, Chieti, Italy
    Int J Immunopathol Pharmacol 24:673-81. 2011
  7. ncbi request reprint The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients
    Marcella Reale
    Department of Oncology and Neuroscience, Unit of Immunology, University G D Annunzio, Via dei Vestini 31, 66123 Chieti, Italy
    Neuropharmacology 50:606-13. 2006
  8. ncbi request reprint Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines
    Marcella Reale
    Immunology Unit, Department of Oncology and Neuroscience, University UD A, Via dei Vestini, 66013 Chieti, Italy
    J Neuroimmunol 148:162-71. 2004
  9. ncbi request reprint Expression and production of two selected beta-chemokines in peripheral blood mononuclear cells from patients with Alzheimer's disease
    Carla Iarlori
    Department of Oncology and Neuroscience, Chieti, Italy
    Exp Gerontol 40:605-11. 2005
  10. ncbi request reprint Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1 beta and interleukin-6 release from lymphocytes of Alzheimer's disease patients
    Marcella Reale
    Department of Oncology and Neuroscience, Unit of Immunology, University G D Annunzio, Via dei Vestini, 31, 66123 Chieti, Italy
    Exp Gerontol 40:165-71. 2005

Collaborators

  • G Sepede
  • C Feliciani
  • M Reale
  • Theoharis Theoharides
  • P Conti
  • D De Berardis
  • Domenico De Berardis
  • C M Conti
  • R M Salerno
  • N Serroni
  • M Fulcheri
  • A Carano
  • F M Ferro
  • D Campanella
  • Delia Racciatti
  • A Valchera
  • A M Pizzorno
  • R La Rovere
  • B Di Giuseppe
  • F S Moschetta
  • C Cotellessa
  • Raffaella La Rovere
  • Daniela Campanella
  • Filippo Maria Ferro
  • Rosa Maria Salerno
  • Carla Iarlori
  • V Gorgoretti
  • E Pizzigallo
  • L Tancredi
  • M Scali
  • A D'Albenzio
  • Alessandro Valchera
  • Enrico Mancini
  • Laura Core
  • Francesco Saverio Moschetta
  • Eustachio Santilli
  • Gianferruccio Canfora
  • C Sivestrini
  • D Piersanti
  • Mirella Salvatore
  • Laura Penna
  • Alessandra Cicconetti
  • Isabella Lucci
  • Lucia Pelusi
  • Gabriele Salini
  • Domenico Gambi
  • Alessandro Carano
  • Carla Cotellessa

Detail Information

Publications14

  1. ncbi request reprint Effect of mirtazapine on thyroid hormones in adult patients with major depression
    F Gambi
    Department of Oncology and Neurosciences, Institute of Psychiatry, University G D Annunzio, Chieti, Italy
    Int J Immunopathol Pharmacol 18:737-44. 2005
    ..Furthermore, higher FT3 concentrations at endpoint were found to be predictors of lower HAM-D scores. Long-term treatment with mirtazapine increases FT3 levels and decreases FT4 maybe involving the deiodination process of T4 into T3...
  2. ncbi request reprint Mirtazapine treatment of generalized anxiety disorder: a fixed dose, open label study
    Francesco Gambi
    Department of Oncology and Neurosciences, Institute of Psychiatry, University G d Annunzio of Chieti, Chieti, Italy
    J Psychopharmacol 19:483-7. 2005
    ..4% of patients (n=16). This study supports the notion that mirtazapine is an efficacious and well tolerated treatment for GAD. Limitations of the present study must be considered and further placebo-controlled trials are needed...
  3. ncbi request reprint Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder
    D De Berardis
    Department of Oncology and Neurosciences, Institute of Psychiatry, G D Annunzio University, Chieti, Italy
    J Biol Regul Homeost Agents 22:195-200. 2008
    ..However, limitations should be considered and further studies are needed...
  4. ncbi request reprint Evaluation of C-reactive protein and total serum cholesterol in adult patients with bipolar disorder
    D De Berardis
    Department of Oncology and Neurosciences, Institute of Psychiatry, G D Annunzio University of Chieti, Palazzina SE BI, Scuole di Specializzazione, Via dei Vestini 29, Chieti, Italy
    Int J Immunopathol Pharmacol 21:319-24. 2008
    ..TC levels were negatively correlated to BRMRS, YMRS and HAM-D. In conclusion, the results of the present study support the notion that CRP and TC may be altered in patients with BP-I...
  5. ncbi request reprint The role of C-reactive protein in mood disorders
    D De Berardis
    Institute of Psychiatry, Department of Oncology and Neurosciences, University of Chieti, Chieti, Italy
    Int J Immunopathol Pharmacol 19:721-5. 2006
    ..In conclusion, the role of CRP in mood disorders is, to date, intriguing but somewhat unclear. Further prospective studies are needed to introduce the CRP in clinical settings as a marker of affective states and suicidability...
  6. ncbi request reprint An Italian study on health-related quality of life and fatigue in patients with chronic fatigue syndrome and patients with chronic HCV virus infection: similarities and differences
    Delia Racciatti
    Clinic of Infectious Diseases, Department of Medicine and Aging, G D Annunzio University, Chieti, Italy
    Int J Immunopathol Pharmacol 24:673-81. 2011
    ..In CHC patients the impact of fatigue on HRQoL was less significant than in CFS patients, even though the FIS evaluation showed a significant impairment of the psychosocial domain...
  7. ncbi request reprint The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients
    Marcella Reale
    Department of Oncology and Neuroscience, Unit of Immunology, University G D Annunzio, Via dei Vestini 31, 66123 Chieti, Italy
    Neuropharmacology 50:606-13. 2006
    ..The different amounts of MCP-1 and IL-4 observed might reflect the different states of activation and/or responsiveness of PBMC, that in AD patients could be kept in an activated state by pro-inflammatory cytokines...
  8. ncbi request reprint Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines
    Marcella Reale
    Immunology Unit, Department of Oncology and Neuroscience, University UD A, Via dei Vestini, 66013 Chieti, Italy
    J Neuroimmunol 148:162-71. 2004
    ....
  9. ncbi request reprint Expression and production of two selected beta-chemokines in peripheral blood mononuclear cells from patients with Alzheimer's disease
    Carla Iarlori
    Department of Oncology and Neuroscience, Chieti, Italy
    Exp Gerontol 40:605-11. 2005
    ....
  10. ncbi request reprint Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1 beta and interleukin-6 release from lymphocytes of Alzheimer's disease patients
    Marcella Reale
    Department of Oncology and Neuroscience, Unit of Immunology, University G D Annunzio, Via dei Vestini, 31, 66123 Chieti, Italy
    Exp Gerontol 40:165-71. 2005
    ..In conclusion, the results of this study show that the complex pathology in AD may be reflected in a pattern of altered cytokine secretion from PBMC...
  11. ncbi request reprint Alzheimer patients treated with an AchE inhibitor show higher IL-4 and lower IL-1 beta levels and expression in peripheral blood mononuclear cells
    Francesco Gambi
    Psychiatry Unit, Department of Oncology and Neuroscience, University G D Annunzio, Via dei Vestini, 66013 Chieti, Italy
    J Clin Psychopharmacol 24:314-21. 2004
    ..This increment was observed in both unstimulated and phytohemagglutinin-stimulated peripheral blood mononuclear cells...
  12. ncbi request reprint Alexithymia, fear of bodily sensations, and somatosensory amplification in young outpatients with panic disorder
    Domenico De Berardis
    Dept of Oncology and Neurosciences, Institute of Psychiatry, University G d Annunzio of Chieti, Palazzina SE BI, Scuole di Specializzazione, Via dei Vestini, 31 66013 Chieti Italy
    Psychosomatics 48:239-46. 2007
    ..Results of the present study do not support a direct role of somatosensory amplification in PD. Authors discuss study limitations and future research needs...
  13. ncbi request reprint Insight and alexithymia in adult outpatients with obsessive-compulsive disorder
    Domenico De Berardis
    Department of Oncology and Neurosciences, Institute of Psychiatry, University G D Annunzio of Chieti Palazzina SE BI, Scuole di Specializzazione, Via dei Vestini, 31, 66013, Chieti, Italy
    Eur Arch Psychiatry Clin Neurosci 255:350-8. 2005
    ..To elucidate the relationships between insight and alexithymia in a sample of adult outpatients with obsessive-compulsive disorder (OCD)...
  14. ncbi request reprint Olanzapine augmentation in treatment-resistant panic disorder: a 12-week, fixed-dose, open-label trial
    Gianna Sepede
    Department of Oncology and Neurosciences, Institute of Psychiatry, University G d Annunzio of Chieti, Italy
    J Clin Psychopharmacol 26:45-9. 2006
    ..No extrapyramidal symptoms were reported. Olanzapine appears to be effective as augmentation strategy in the treatment of SSRI-resistant PD, but study limitations must be considered and placebo-controlled studies are needed...